StockDrifts LogoStockDrifts

Curocell 372320

Company
큐로셀Curocell
Insiders
5
Buys
6
Total Value
₩711M ($494K)
Avg Return
+30.54%
Last Filing
2026-06-01

Curocell (372320) has 6 disclosed insider purchases and 2 disclosed disposals on record, filed by 5 distinct insiders. Together those filings cover ₩711M ($494K) in reported transaction value. The earliest filing StockDrifts holds for Curocell is dated 2024-03-08; the most recent is 2026-06-01. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +30.54%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-23BUYMarket Buy
김찬혁
Chanhyuk Kim
-3.1K₩23,950-1.7%₩71M ($49K)
2026-07-22BUYMarket Buy
김찬혁
Chanhyuk Kim
-1.2K₩22,400+5.1%₩29M ($20K)
2026-06-01BUYMarket Buy
박진경
Park Jin-kyung
Managing Director1.0K₩31,350-3.8%₩31M ($22K)
2026-05-08SELLMarket Sell
김수경
Kim Soo-kyung
moving-1.0K₩45,650+19.3%₩46M ($32K)
2026-04-07BUY주식매수선택권
조수희
Jo Soo-hee
Managing Director6.7K₩51,100+19.0%₩341M ($237K)
2026-04-07BUY주식매수선택권
김형철
Kim Hyung-cheol
Managing Director3.0K₩51,100+19.0%₩153M ($106K)
2026-04-07BUY주식매수선택권
서현진
Seo Hyun-jin
Managing Director4.0K₩51,100+19.0%₩204M ($142K)
2026-04-07BUY주식매수선택권
김수경
Kim Soo-kyung
moving2.5K₩51,100+19.0%₩128M ($89K)
2026-03-06BUYMarket Buy
강혁
Kanghyuk
Outside Director400---
2026-01-13BUY주식매수청구권 행사
이영호
Youngho Lee
moving16.3K₩49,300+13.6%₩806M ($560K)
2026-01-01BUY신규선임
김수경
Kim Soo-kyung
moving1.5K₩46,500+20.4%₩68M ($47K)
2025-11-17BUYMarket Buy
전동혁
Jeon Dong-hyuk
Managing Director13.0K₩42,900+30.5%₩558M ($387K)
2025-10-14BUY주식매수청구권 행사
이영호
Youngho Lee
moving3.4K₩39,500+41.8%₩134M ($93K)
2025-08-22SELL임원퇴임
김정근
Kim Jeong-geun
moving-7.5K₩34,800-60.9%₩261M ($181K)
2025-07-31BUYMarket Buy
강혁
Kanghyuk
Outside Director500₩34,500+62.3%₩17M ($12K)
2025-07-21BUY주식매수선택권
김정근
Kim Jeong-geun
moving7.5K₩35,300+58.6%₩265M ($184K)
2025-07-15SELLMarket Sell
이영호
Youngho Lee
moving-450₩31,800-76.1%₩14M ($10K)
2025-04-11BUY주식매수청구권 행사
이영호
Youngho Lee
moving919₩26,400+112.1%₩24M ($17K)
2025-04-11BUY주식매수청구권 행사
전동혁
Jeon Dong-hyuk
Managing Director44.5K₩26,400+112.1%₩1.2B ($816K)
2025-04-11BUY주식매수선택권
조수희
Jo Soo-hee
Managing Director6.7K₩26,400+112.1%₩176M ($122K)
2024-12-13BUYMarket Buy
강혁
Kanghyuk
Outside Director600₩27,000+107.4%₩16M ($11K)
2024-11-11BUY기타
서현진
Seo Hyun-jin
Managing Director500₩28,750+94.8%₩14M ($10K)
2024-11-11BUY기타
이영호
Youngho Lee
moving873₩28,750+94.8%₩25M ($17K)
2024-09-27BUY주식매수선택권
서현진
Seo Hyun-jin
Managing Director5.0K₩28,900+93.8%₩145M ($100K)
2024-04-05BUY주식매수선택권
이영호
Youngho Lee
moving6.0K₩30,500+83.6%₩183M ($127K)
2024-04-05BUY주식매수청구권 행사
전동혁
Jeon Dong-hyuk
Managing Director70.0K₩30,500+83.6%₩2.1B ($1.5M)
2024-04-05BUY주식매수선택권
조수희
Jo Soo-hee
Managing Director6.7K₩30,500+83.6%₩203M ($141K)
2024-03-08BUYMarket Buy
강혁
Kanghyuk
Outside Director900₩32,150+74.2%₩29M ($20K)

Frequently asked questions

Who has been buying Curocell stock?
5 distinct insiders have filed 6 disclosed insider purchases in Curocell (372320), most recently on 2026-06-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Curocell have?
Curocell has 6 buy-side and 2 sell-side disclosures on record, covering ₩711M ($494K) in total reported value, spanning 2024-03-08 to 2026-06-01.
Where does StockDrifts get Curocell insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Curocell. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.